One-hour test could help doctors better spot memory problems
With the expected worldwide rise in all-cause dementia to approximately 152.8 million by the year 2050 and the potential for disease-modifying therapies such as anti-amyloid monoclonal antibodies, there will be an increased demand on neurologists and memory clinics to rapidly identify and stage patients with Alzheimer's disease (AD) and related dementias. While neuropsychological assessment…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
